Syndax Pharmaceuticals SNDX Change in Other Current Assets
Change in Other Current Assets at other companies
Other financials
Where this comes from
Reported directly by Syndax Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherCurrentAssets.
The official record: Syndax Pharmaceuticals’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Syndax Pharmaceuticals's change in other current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Syndax Pharmaceuticals's change in other current assets?
- Syndax Pharmaceuticals (SNDX) reported change in other current assets of $0 in Q4 2025.
- How has Syndax Pharmaceuticals's change in other current assets changed year-over-year?
- Syndax Pharmaceuticals's change in other current assets increased by 100.0% year-over-year, from -$115.75K to $0.
- What does change in other current assets mean?
- Change in miscellaneous current assets not classified in specific working capital categories.